QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)

Best Stocks Under $30.00 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $30.00 (30 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.


JD Sports Fashion stock logo

#1 - JD Sports Fashion

OTCMKTS:JDSPY
Stock Price: $2.39 (+$0.04)
Average Trading Volume: 2,471 shares
Consensus Rating: Strong Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $203.33 (8,407.7% Upside)
JD Sports Fashion Plc retails and distributes sports fashion wear and outdoor clothing and equipment. It operates through the Sports Fashion and Outdoor segments. The Sports Fashion segment consists of JD Sports Fashion Plc, John David Sports Fashion (Ireland) Limited, Spodis SA, Champion Sports Ireland, JD Sprinter Holdings 2010 SL, JD Sports Fashion BV, JD Sports Fashion Germany GmbH, JD Sports Fashion SRL, Duffer of St George Limited, Topgrade Sportswear Limited, Kooga Rugby Limited, Focus Brands Limited, Kukri Sports Limited, Source Lab Limited, R.D. Scott Limited, Tessuti Group Limited, Nicholas Deakins Limited, Cloggs Online Limited, Ark Fashion Limited and Mainline Menswear Limited. The Outdoor segment consists of Blacks Outdoor Retail Ltd. Tiso Group Ltd and ActivInstinct Limited. The company was founded by John Carruthers Wardle and David Martin Makin in 1981 and is headquartered in Bury, the United Kingdom.
Northland Power stock logo

#2 - Northland Power

OTCMKTS:NPIFF
Stock Price: $21.81 (-$0.59)
PE Ratio: -68.99
Average Trading Volume: 9,754 shares
Dividend Yield: 7.24%
Consensus Rating: Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $50.75 (132.7% Upside)
Northland Power, Inc. engages in the development, building, owning, and management of wind facilities. It operates through the following segments: Offshore Wind, Efficient Natural Gas, Onshore Renewable, Utility, and Other. The Offshore Wind segment consists of Gemini, Nordsee One, and Deutsche Bucht projects. The Onshore Renewables segment consists of Solar, Grand Bend, Jardin, Mont Louis, Cochrane, McLeans, and La Lucha projects. The Efficient Natural Gas includes North Battleford, Iroquois Falls, Kirkland Lake, Kingston, Thorold, and Spy Hill projects. The Utility segment operates Empresa de Energía de Boyacá S.A E.S.P. (EBSA) project. The Other segment focuses on investment income and administration activities. The company was founded by James C. Temerty in 1987 and is headquartered in Toronto, Canada.
Everi stock logo

#3 - Everi

NYSE:EVRI
Stock Price: $14.72 (+$0.04)
PE Ratio: 12.17
Market Cap: $1.31 billion
Average Trading Volume: 747,942 shares
P/E Ratio: 12.2
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $26.20 (78.0% Upside)
Everi Holdings, Inc. engages in the provision of technology solutions to the casino, interactive, and gaming industry. It operates through the Games and Financial Technology Solutions (FinTech) segments. The Games segment focuses on leased gaming equipment, sales of gaming equipment, gaming systems, interactive solutions, and ancillary products and services. The FinTech segment provides access to cash at gaming facilities via ATM cash withdrawals, credit card cash access transactions and point of sale debit card cash access transactions, check-related services, fully integrated kiosks and maintenance services, compliance, audit and data software, casino credit data, and reporting services and other ancillary offerings. The company was founded on February 4, 2004 and is headquartered in Las Vegas, NV.
Mirum Pharmaceuticals stock logo

#4 - Mirum Pharmaceuticals

NASDAQ:MIRM
Stock Price: $26.05 (-$0.12)
PE Ratio: -7.14
Market Cap: $990.68 million
Average Trading Volume: 448,126 shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $49.00 (88.1% Upside)
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Ocular Therapeutix stock logo

#5 - Ocular Therapeutix

NASDAQ:OCUL
Stock Price: $6.37 (-$0.01)
PE Ratio: -5.35
Market Cap: $493.87 million
Average Trading Volume: 1.30 million shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $12.80 (100.9% Upside)
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Dyne Therapeutics stock logo

#6 - Dyne Therapeutics

NASDAQ:DYN
Stock Price: $13.16 (-$0.41)
PE Ratio: -3.95
Market Cap: $767.36 million
Average Trading Volume: 349,746 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.83 (96.3% Upside)
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
InflaRx stock logo

#7 - InflaRx

NASDAQ:IFRX
Stock Price: $4.37 (-$0.38)
PE Ratio: -7.05
Market Cap: $195.34 million
Average Trading Volume: 1.66 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $14.00 (220.4% Upside)
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Avidity Biosciences stock logo

#8 - Avidity Biosciences

NASDAQ:RNA
Stock Price: $10.69 (-$0.32)
PE Ratio: -3.18
Market Cap: $757.07 million
Average Trading Volume: 1.15 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $42.60 (298.5% Upside)
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Skyward Specialty Insurance Group stock logo

#9 - Skyward Specialty Insurance Group

NASDAQ:SKWD
Stock Price: $24.06 (-$0.11)
Market Cap: $906.05 million
Average Trading Volume: 194,037 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $26.67 (10.8% Upside)
Skyward Specialty Insurance Group Inc. is an insurance holding company, engages in underwriting commercial property and casualty insurance coverages principally in the United States. Skyward Specialty Insurance Group Inc. is based in Houston, Texas.
Graphic Packaging stock logo

#10 - Graphic Packaging

NYSE:GPK
Stock Price: $25.63 (-$0.14)
PE Ratio: 12.82
Market Cap: $7.87 billion
Average Trading Volume: 3.11 million shares
P/E Ratio: 12.8
Dividend Yield: 1.57%
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $28.78 (12.3% Upside)
Graphic Packaging Holding Co. engages in the provision of paper-based packaging solutions for a variety of products to food, beverage and other consumer products companies. It operates through the following business segments: Paperboard Mills, Americas Paperboard Packaging, Europe Paperboard Packaging, and Corporate and Other. The Paperboard Mills segment includes the eight North American paperboard mills which produce coated unbleached kraft paperboard and coated-recycled paperboard. The Americas Paperboard Packaging segment consists of paperboard folding cartons sold to consumer-packaged goods companies serving the food, beverage and consumer product markets in the Americas. The Europe Paperboard Packaging segment provides paperboard folding cartons sold to consumer-packaged goods companies serving the food, beverage and consumer product markets in Europe. The Corporate and Other segment deals with the Pacific Rim and Australia operating segments and unallocated corporate and one-time costs. The company was founded on December 28, 1992, and is headquartered in Atlanta, GA.
89bio stock logo

#11 - 89bio

NASDAQ:ETNB
Stock Price: $16.91 (-$0.73)
PE Ratio: -6.00
Market Cap: $1.23 billion
Average Trading Volume: 1.81 million shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $34.00 (101.1% Upside)
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Energy Transfer stock logo

#12 - Energy Transfer

NYSE:ET
Stock Price: $12.72 (+$0.19)
PE Ratio: 9.49
Market Cap: $39.96 billion
Average Trading Volume: 12.16 million shares
P/E Ratio: 9.5
Dividend Yield: 9.87%
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $16.43 (29.2% Upside)
Energy Transfer LP provides natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acq
CymaBay Therapeutics stock logo

#13 - CymaBay Therapeutics

NASDAQ:CBAY
Stock Price: $9.05 (-$0.11)
PE Ratio: -7.67
Market Cap: $882.47 million
Average Trading Volume: 1.65 million shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $14.57 (61.0% Upside)
CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.
Atlas Energy Solutions stock logo

#14 - Atlas Energy Solutions

NYSE:AESI
Stock Price: $17.54 (+$0.03)
Market Cap: $1.75 billion
Average Trading Volume: 481,299 shares
Dividend Yield: 0.86%
Consensus Rating: Buy (9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $24.44 (39.4% Upside)
Atlas Energy Solutions Inc. is a provider of proppant and logistics services to customers engaged in the oil and natural gas industry principally within the Permian Basin of West Texas and New Mexico. Atlas Energy Solutions Inc. is based in AUSTIN, Texas.
Xencor stock logo

#15 - Xencor

NASDAQ:XNCR
Stock Price: $26.05 (-$0.46)
PE Ratio: -11.13
Market Cap: $1.57 billion
Average Trading Volume: 350,106 shares
Consensus Rating: Buy (11 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $45.33 (74.0% Upside)
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Halliburton stock logo

#16 - Halliburton

NYSE:HAL
Stock Price: $29.87 (+$0.93)
PE Ratio: 13.83
Market Cap: $26.95 billion
Average Trading Volume: 9.43 million shares
P/E Ratio: 13.8
Dividend Yield: 2.30%
Consensus Rating: Buy (14 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $48.24 (61.5% Upside)
Halliburton Co. engages in the provision of services and products to the energy industry related to the exploration, development, and production of oil and natural gas. It operates through the Completion and Production, and Drilling and Evaluation segments. The Completion and Production segment delivers cementing, stimulation, intervention, pressure control, specialty chemicals, artificial lift, and completion services. The Drilling and Evaluation segment provides field and reservoir modeling, drilling, evaluation, and wellbore placement solutions that enable customers to model, measure, and optimize their well construction activities. The company was founded by Erle P. Halliburton in 1919 and is headquartered in Houston, TX.
ADENTRA stock logo

#17 - ADENTRA

OTCMKTS:HDIUF
Stock Price: $21.07
PE Ratio: 25.90
Average Trading Volume: 1,323 shares
P/E Ratio: 25.9
Dividend Yield: 1.51%
Consensus Rating: Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $48.67 (131.0% Upside)
ADENTRA, Inc. engages in the sourcing and distribution of architectural grade building products to the residential and commercial construction sectors. The firm's products include hardwood lumber, decorative surfaces and composite panels. It operates through the following geographical segments: Canada and United States. The company was founded on April 5, 2011 and is headquartered in Langley, Canada.
Integra Resources stock logo

#18 - Integra Resources

NYSEMKT:ITRG
Stock Price: $0.49 (-$0.01)
PE Ratio: -1.67
Market Cap: $39.08 million
Average Trading Volume: 105,321 shares
Consensus Rating: Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.58 (432.0% Upside)
Integra Resources Corp., a mineral resources company, engages in the acquisition, exploration, and development of mineral properties in the Americas. It primarily focuses on the development of DeLamar project that consists of DeLamar and Florida Mountain gold and silver deposits comprising 790 unpatented lode, placer, and millsite claims, as well as 16 tax parcels covering an area of approximately 8,673 hectares located in the Owyhee County, south western Idaho. The company was formerly known as Mag Copper Limited and changed its name to Integra Resources Corp. in August 2017. Integra Resources Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
MakeMyTrip stock logo

#19 - MakeMyTrip

NASDAQ:MMYT
Stock Price: $25.92 (-$0.38)
PE Ratio: -136.42
Market Cap: $2.73 billion
Average Trading Volume: 320,542 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $41.00 (58.2% Upside)
MakeMyTrip Ltd. is an online travel company. Its services and products include air ticketing, hotels and packages, rail tickets, bus tickets, car hire, experiences and ancillary travel requirements such as facilitating access to third-party travel insurance and visa processing. The company's brands include MakeMyTrip, goibibo, and redbus. It operates through the following three segments: Air Ticketing, Hotels and Packages, and Bus Ticketing. The Air Ticketing segment provides the facility to book domestic and international air tickets. The Hotels and Packages segment provides holiday packages and hotel reservations. The Bus Ticketing segment provides the facility to book domestic and international bus tickets. MakeMyTrip was founded by Deep Kalra and Rajesh Magow on April 28, 2000 and is headquartered in Gurgaon, India.
Taseko Mines stock logo

#20 - Taseko Mines

NYSEAMERICAN:TGB
Stock Price: $1.39 (-$0.02)
PE Ratio: -17.38
Market Cap: $400.90 million
Average Trading Volume: 1.22 million shares
Consensus Rating: Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.73 (96.4% Upside)
Taseko Mines Ltd. operates as a mining company engaged in the acquisition, development, and operation of mineral deposits. It holds interest in the Gibraltar, Florence Copper, Aley Niobium, Yellowhead, New Prosperity, and Harmony projects. The company was founded on April 15, 1966 and is headquartered in Vancouver, Canada.
Imperial Brands stock logo

#21 - Imperial Brands

OTCMKTS:IMBBY
Stock Price: $22.18 (-$0.52)
Market Cap: $20.46 billion
Average Trading Volume: 144,764 shares
Dividend Yield: 10.52%
Consensus Rating: Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2,210.00 (9,866.2% Upside)
Imperial Brands Plc is a holding company which engages in the manufacture and sale of cigarettes, tobaccos, cigars, rolling papers, and tubes. It operates through the Tobacco and Next Generation Product (NGP), and Distribution segments. The Tobacco and NGP segment manufactures, markets, and sells Tobacco and NGP, and its related products. The Distribution segment is involved in the distribution of tobacco and NGP products for product manufacturers, including Imperial Brands. The company was founded in 1636 and is headquartered in Bristol, the United Kingdom.
Thorne HealthTech stock logo

#22 - Thorne HealthTech

NASDAQ:THRN
Stock Price: $4.38 (-$0.11)
PE Ratio: 23.05
Market Cap: $235.91 million
Average Trading Volume: 48,069 shares
P/E Ratio: 23.1
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $6.92 (57.9% Upside)
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
SI-BONE stock logo

#23 - SI-BONE

NASDAQ:SIBN
Stock Price: $26.12 (+$0.89)
PE Ratio: -16.43
Market Cap: $918.90 million
Average Trading Volume: 334,236 shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.29 (-3.2% Upside)
SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 2008 and is headquartered in Santa Clara, CA.
PROS stock logo

#24 - PROS

NYSE:PRO
Stock Price: $28.43 (+$1.12)
PE Ratio: -17.77
Market Cap: $1.31 billion
Average Trading Volume: 258,003 shares
Consensus Rating: Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $34.00 (19.6% Upside)
PROS Holdings, Inc. engages in the provision of solutions that optimize the processes of selling and shopping in the digital economy. Its solutions selling, pricing, and revenue management leverage artificial intelligence (AI), self-learning and automation to ensure that every transactional experience is fast, frictionless and personalized for every shopper, supporting both business-to-business (B2B) and business-to-consumer (B2C) companies across industry verticals. The company was founded by Mariette M. Woestemeyer and Ronald F. Woestemeyer in 1985 and is headquartered in Houston, TX.
PrairieSky Royalty stock logo

#25 - PrairieSky Royalty

OTCMKTS:PREKF
Stock Price: $16.94 (-$0.07)
Average Trading Volume: 17,001 shares
Dividend Yield: 4.92%
Consensus Rating: Buy (3 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.50 (50.5% Upside)
PrairieSky Royalty Ltd. engages in seeking and development of petroleum and natural gas royalty assets. The firm is also involved in generating royalty production revenues as petroleum and natural gas produced from its properties. The company was founded on November 27, 2013 and is headquartered in Calgary, Canada.

More Stock Ideas from MarketBeat

My Account -